Chad Johannes

Dr. Johannes joined Colorado State University in January 2022, after seven years of developing the oncology program at Iowa State University. His industry experience includes former medical director at Aratana Therapeutics, and coordinating the launch of Palladia® during his time with Zoetis. Dr. Johannes’s practice experience includes primary care, specialty care, and academic settings. His areas of research interest include oncology therapeutic development and market introduction, environmental causes of cancer, and effective management of treatment-related side effects.